Trial intelligence / Profile preview

Vitamin D in CAD Patients with Postchallenge Hyperglycemia

NCT01183442Phase 3Terminated

Sponsor
Medical University of Graz
Start
Jun 2010
Primary completion
Nov 2012
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of vitamin d in Vitamin D deficiency (VDD) and postprandial hyperglycemia (PPH), sponsored by Medical University of Graz. Started Jun 2010; status: terminated.

02

Drugs

vitamin d
03

Conditions

Vitamin D deficiency (VDD)postprandial hyperglycemia (PPH)

Beyond the preview

Go deeper on NCT01183442.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01183442.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call